Insights accelerated
Traditional market testing in pharma is slow, expensive, and rarely candid. Marketing, medical and access teams need a faster way to see how patients and prescribers will respond before an idea ships.
AudienceIQ is a synthetic persona panel, run by our strategy and medical teams.
It's built on published research, public datasets and real patient and prescriber conversations. And it's fast, so you can pressure-test concepts, messages and objection responses in hours instead of months.
The problem with traditional testing
Ideas get tested against opinion, not evidence. Real testing costs time and money, so it's the first thing to be cut. And when testing does happen, it's in a controlled setting where candid reactions are rare.
Every angle,
backed by evidence
AudienceIQ helps you understand Australian patient and prescriber audiences, map their journeys, and test which concepts, messages and strategies will land before launch, quickly and cost-effectively. It simulates responses from public datasets, published research, real-world conversations and, where available, your own research.
AudienceIQ can be used to answer the questions that are often too narrow, too niche or too early-stage for traditional research. For example:
The audience
Who they are, including populations that may be too small or specialised for a traditional study, and what drives their decisions emotionally and rationally.
The journey
Where trust stalls, where drop-offs happen, and where brand, CX or UX issues create friction for patients or prescribers.
The idea
How campaigns, concepts, messaging, positioning or creative territories are likely to land before they go live.
The objection
Where resistance may come from, what concerns need to be addressed, and how to handle them before launch.
Here's how it works
Bring your research
AudienceIQ can use your research to enhance the final output. Don't have any research? AudienceIQ is built on published research, public datasets and real-world conversations.
Build the panel
Select or build the Australian patient and prescriber segments relevant to your therapy area, sized against the market, and map their journey.
Test your idea
Test concepts, strategies, messaging, objection responses or existing materials, and see how patients and prescribers could think, feel and act.
Get a plain-English readout
Verbatim reactions, a scorecard for quick reference, and every finding flagged as grounded in real evidence or a directional read.
The output for you
AudienceIQ gives you a plain-English readout so you can understand and act on the results quickly*. For every segment you build, you'll receive detailed personas and a clear map of their journey. When you present your idea to the panel, you will receive:
What's working and why
What needs more work
What would make it land
Issues you may have missed
*Your data stays private and secure.
Why choose AudienceIQ
AudienceIQ cuts the time and cost out of market testing. No more guessing what your audience is thinking, just a clear readout of what's working, what needs work, and what to do next.
Patient centricity & AI
At NEXT Pharma, three voices will discuss how AI actually puts patients back at the centre of pharma decisions.
Darran Foo
Chief Medical Information Officer, Heidi (practising GP)
Heidi Health builds practical AI tools designed to save time and reduce administrative burden, supporting GPs directly in clinical settings. As a practising GP, Darran will bring a clinical perspective to the panel and ground the discussion in the realities of everyday practice.
heidihealth.com
David Thomas
Director, Centre for Molecular Oncology, UNSW / Omico
Omico exists to get precision cancer medicine to patients faster. David will bring a clinical trial lens to the panel and explore whether faster, AI-assisted profiling could change who gets access to the right treatments first.
omico.com.au
Mikaela Crimmins
Chief Strategy Officer, Orchard
Mikaela leads the strategy team behind AudienceIQ. As Chief Strategy Officer of Orchard, Mikaela will bring a commercial strategy perspective to the panel and examine whether healthcare marketing decisions are being shaped by genuine patient beliefs and behaviours, or by what suits the business.
orchard.com.au